| 02/06/2019 | René-Jean BENSADOUN | |
Radiation Oncologist, MD, HDR,
Professor in Radiation Oncology,
Current Position: Chairman, Centre de Haute Energie, NICE (France)
Fields of Interest: Radiation Oncology, Head & Neck Cancer, Supportive Care in Cancer, Low Level LaserTherapy, New techniques in Radiation Oncology (IMRT, VMAT), Cancer-treatment toxicity.
Boards:
WALT President-Elect (2018), past-Scientific Secretary (2015-2017) (World Association for Photobiomodulation Therapy)
Deputy Associate Editor of JSCC (Journal of Supportive Care in Cancer)
Member of MASCC-ISOO Mucositis Board and Oral Care Board
Membre de l’APPAC, de l’EMLA, et de la LED Academy (LED & LLLT)
Board Member of SFCCF and GORTEC (H & N Cancer French Groups)
Membre du Conseil d’Administration de l’AFSOS (S. Support)
Member of ESMO Toxicity Working Group.
Professional Experience
| Jan 2014 – today | Chairman Centre De Haute Energie, Nice, Radiotherapy |
| Aug 2008 – Dec 2013 | Head of Department Centre Hospitalier Universitaire de Poitiers, Department of Radiation Oncology Poitiers, France |
| Aug 2008 – Dec 2013 | Professor (Full) Université de Poitiers, UFR Medecine et Pharmacie Poitiers, France |
| Mar 2008 – Jul 2008 | Research Associate Institut Universitaire de la Face et du Cou - de Nice et Centre Lacassagne, Nice, France |
| Sep 2004 – present | cooperation, expertise Assiut University, Assiut Cancer Center Asyūţ, Egypt |
| Sep 1999 – Jul 2008 | Research Associate University of Nice-Sophia Antipolis, Faculty of Sciences Valbonne, France |
| May 1996 – Jul 2008 | Head of Radiotherapy Unit Centre Antoine-Lacassagne, Radiation Oncology Nice, France. |
PUBLICATIONS:
192 peer-reviewed papers, 85 as first or corresponding author.
2 Books, 5 book chapters.
H index 40. Comprehensive impact factor: 980,8.
GRANTS:
06/2017: National Grant (INCA, French National Cancer Institute) for PBM-LLLT Dosimetry (with Pr O. Caselles, “Institut du Cancer de Toulouse”, and Dr. M Pelletier (Toulon).
05/2019: European Grant for a new PBM randomized trial in mucositis and dermatitis prevention.